Orange Book product · Generic (ANDA)
CARISOPRODOL
CARISOPRODOL
At a glance
May 11, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 11, 2017
9 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
CARISOPRODOL
Strength
250MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 207237
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARISOPRODOL
- —SOMABrand (NDA)
NDA 011792 · MYLAN SPECIALITY LP
- —RELABrand (NDA)
NDA 012155 · SCHERING
- 2021CARISOPRODOLGeneric (ANDA)
ANDA 211789 · POINTVIEW HLDINGS
- 2016CARISOPRODOLGeneric (ANDA)
ANDA 040792 · AUROBINDO PHARMA
- 2015CARISOPRODOLGeneric (ANDA)
ANDA 205513 · STRIDES PHARMA
- 2015CARISOPRODOLGeneric (ANDA)
ANDA 205126 · HERITAGE
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 090988 · NATCO
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 205085 · ORIENT PHARMA CO LTD
- 2014CARISOPRODOLGeneric (ANDA)
ANDA 203374 · SCIEGEN PHARMS
- 2008CARISOPRODOLGeneric (ANDA)
ANDA 040823 · INGENUS PHARMS LLC
- 2007CARISOPRODOLGeneric (ANDA)
ANDA 040755 · SUN PHARM INDS LTD
- 2005CARISOPRODOLGeneric (ANDA)
ANDA 040576 · ACCELRX LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
